More Clinical Articles

Clinical

Introducing the Behavioral Element to Clinical Trials

Dr Nicola Davies, (Sep 29, 2015)

We explore a new trial design that takes into consideration the behavioral elements of participants - the 2 x 2 trial design.
Clinical

Personalized Medicine Ultimate Form of Patient-Centricity

Zuzanna Fimińska, (Sep 14, 2015)

Customized treatments are the final step in putting patients at the center of pharma’s operations.
Clinical

Artificial Intelligence – A Brave New World for Pharma

Dr Nicola Davies, (Sep 1, 2015)

Dr Andree Bates explains how artificial intelligence can help reduce trial time, crunch data, and facilitate healing.
Clinical

Bridging the Diversity Gap in Clinical Trials

Danielle Barron, (Aug 12, 2015)

Melva Covington on strategies to encourage the production of clinical-trial data that more accurately reflects real-world diversity.
Clinical

Medication Adherence Platforms: A New Way to Optimize Clinical Trial Outcomes

Moses Zonana, (Jul 28, 2015)

About half of new drug compounds fail to demonstrate efficacy in therapeutic trials. The root cause - low medication adherence.
Clinical

Patient-Reported Outcome Measures for Cystic Fibrosis

Dr Nicola Davies, (Jul 23, 2015)

Dr Nicola Davies explores the utility of PROMs in pharma, with a focus on cystic fibrosis.
Clinical

A Master Framework for Patient Centricity

Danielle Barron, (Jul 17, 2015)

Jeff Sherman on why industry engagement with patients should be thought of as a long-term relationship.
Clinical

Change Catalyst in Clinical Research

Paul Simms, (Jul 15, 2015)

Dr. Jeffrey Kasher, Chairman of the DrugDev Advisory Board on his mission to fundamentally change the clinical research process.
Clinical

Better Decision Making through Better Patient Insights

Danielle Barron, (Jun 24, 2015)

True two-way engagement in clinical trials is now a possibility.
Clinical

PROMs: Giving Patients a Voice

Dr Nicola Davies, (Jun 3, 2015)

Why PROMs should be embraced by pharma.

Pages